Literature DB >> 2155045

Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems.

N H Kalin1, L K Takahashi.   

Abstract

In earlier studies, we established that in rats, antagonism of corticotropin-releasing hormone (CRH) receptors reduced the occurrence of fear-motivated behavior displayed immediately after administration of electric foot shock. Because exposure to stress is reported to have long-term behavioral and physiological effects, we examined whether central administration of the synthetic CRH receptor antagonist, alpha-helical CRH(9-41), would also alter fear-motivated behavioral and hormonal responses occurring 24 h after exposure to electric foot shock. Adult male rats were placed in a shock box and administered three, 1.0 mA foot shocks. Twenty-four hours later, rats received an intracerebroventricular infusion of 20 micrograms of alpha-helical CRH(9-41) or vehicle 20 min before re-exposure to the shock box. Antagonism of CRH receptors produced a significant reduction in fear-motivated freezing. However, stress-induced analgesia and plasma adrenocorticotropin concentrations did not differ significantly from vehicle-treated animals. In order to assess whether the reduction in freezing was due to intrinsic actions of the CRH receptor antagonist, non-shocked rats received central infusions of alpha-helical CRH(9-41) prior to re-exposure to the test box. Under these conditions, behavior exhibited by antagonist- and vehicle-treated rats did not differ significantly. Results suggest that the reduction in fear-motivated behavior is mediated by antagonism of endogenous CRH receptors and occurs independently of analgesic and hormonal reactions induced by prior exposure to stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155045     DOI: 10.1016/0006-8993(90)90311-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.

Authors:  E Keen-Rhinehart; V Michopoulos; D J Toufexis; E I Martin; H Nair; K J Ressler; M Davis; M J Owens; C B Nemeroff; M E Wilson
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

Review 2.  Nesfatin-1: a novel inhibitory regulator of food intake and body weight.

Authors:  A Stengel; M Goebel; Y Taché
Journal:  Obes Rev       Date:  2011-04       Impact factor: 9.213

3.  Cortisol suppression by dexamethasone reduces exaggerated fear responses in posttraumatic stress disorder.

Authors:  Tanja Jovanovic; Justine E Phifer; Katie Sicking; Tamara Weiss; Seth D Norrholm; Bekh Bradley; Kerry J Ressler
Journal:  Psychoneuroendocrinology       Date:  2011-05-20       Impact factor: 4.905

4.  Corticotropin releasing factor type-1 receptor antagonism in the dorsolateral bed nucleus of the stria terminalis disrupts contextually conditioned fear, but not unconditioned fear to a predator odor.

Authors:  Arun Asok; Jay Schulkin; Jeffrey B Rosen
Journal:  Psychoneuroendocrinology       Date:  2016-04-28       Impact factor: 4.905

5.  Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study.

Authors:  Vasiliki Michopoulos; Seth D Norrholm; Jennifer S Stevens; Ebony M Glover; Barbara O Rothbaum; Charles F Gillespie; Ann C Schwartz; Kerry J Ressler; Tanja Jovanovic
Journal:  Psychoneuroendocrinology       Date:  2017-05-31       Impact factor: 4.905

6.  Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain.

Authors:  D S Albeck; C R McKittrick; D C Blanchard; R J Blanchard; J Nikulina; B S McEwen; R R Sakai
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

7.  Nesfatin-1 increases anxiety- and fear-related behaviors in the rat.

Authors:  Z Merali; C Cayer; P Kent; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  2008-08-01       Impact factor: 4.530

Review 8.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Traits of fear resistance and susceptibility in an advanced intercross line.

Authors:  Jennifer L McGuire; Hadley C Bergstrom; Clarissa C Parker; Thien Le; Maria Morgan; Haiying Tang; Reed G Selwyn; Afonso C Silva; Kwang Choi; Robert J Ursano; Abraham A Palmer; Luke R Johnson
Journal:  Eur J Neurosci       Date:  2013-08-22       Impact factor: 3.386

10.  Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.

Authors:  C L Pickens; T Adams-Deutsch; S G Nair; B M Navarre; M Heilig; Y Shaham
Journal:  Neuroscience       Date:  2009-10-02       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.